Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Leypoldt LB, Tichy D, Besemer B, Hänel M, Raab MS, Mann C, Munder M, Reinhardt HC, Nogai A, Görner M, Ko YD, de Wit M, Salwender H, Scheid C, Graeven U, Peceny R, Staib P, Dieing A, Einsele H, Jauch A, Hundemer M, Zago M, Požek E, Benner A, Bokemeyer C, Goldschmidt H, Weisel KC. Leypoldt LB, et al. Among authors: nogai a. J Clin Oncol. 2024 Jan 1;42(1):26-37. doi: 10.1200/JCO.23.01696. Epub 2023 Sep 27. J Clin Oncol. 2024. PMID: 37753960 Free PMC article.
A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.
Penack O, Fischer L, Stroux A, Gentilini C, Nogai A, Muessig A, Ganepola S, Lange T, Kliem C, Marinets O, Blau IW, Thiel E, Uhareka L. Penack O, et al. Among authors: nogai a. Int J Hematol. 2007 May;85(4):326-32. doi: 10.1532/IJH97.E0622. Int J Hematol. 2007. PMID: 17483077 Clinical Trial.
Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation.
Penack O, Fischer L, Stroux A, Gentilini C, Nogai A, Muessig A, Rieger K, Ganepola S, Herr W, Meyer RG, Thiel E, Uharek L. Penack O, et al. Among authors: nogai a. Bone Marrow Transplant. 2008 Feb;41(4):377-83. doi: 10.1038/sj.bmt.1705911. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982494
Organ siderosis and hemophagocytosis during acute graft-versus-host disease.
Nogai A, Shi Y, Pérez-Hernandez D, Cordes S, Mengwasser J, Mertlitz S, Riesner K, Kalupa M, Erdmann JH, Ziebig R, Dittmar G, Penack O. Nogai A, et al. Haematologica. 2016 Aug;101(8):e344-6. doi: 10.3324/haematol.2016.144519. Epub 2016 May 19. Haematologica. 2016. PMID: 27198715 Free PMC article. No abstract available.
[Space-occupying lesion in the maxillary sinus].
Lohneis P, Nogai A, Niehues SM, Jöhrens K, Anagnostopoulos I. Lohneis P, et al. Among authors: nogai a. Pathologe. 2016 Nov;37(6):568-572. doi: 10.1007/s00292-016-0213-5. Pathologe. 2016. PMID: 27534543 German.
Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.
Hilgendorf I, Wolff D, Nogai A, Kundt G, Hahn J, Holler E, Uharek L, Junghanss C, Leithäuser M, Thiel E, Freund M, Kahl C. Hilgendorf I, et al. Among authors: nogai a. Onkologie. 2012;35(9):487-92. doi: 10.1159/000341835. Epub 2012 Aug 13. Onkologie. 2012. PMID: 23007145 Clinical Trial.
32 results